1.Impact of dairy farming on gut microbiota structure and diversity of practitioners
Zhaojie WANG ; Xixiao MA ; Xianxia LIU ; Yanggui CHEN ; Xueying XIANG ; Wanting XU ; Jiguo JIN ; Fan WU ; Xiangnan WEI ; Jianyong WU ; Fuye LI
Journal of Environmental and Occupational Medicine 2025;42(6):668-673
		                        		
		                        			
		                        			Background Animal farming may affect the structure and diversity of gut microbiota of farm workers, but it needs more studies to provide solid evidence. Objective To analyze the diversity characteristics of gut microbiota in dairy farm workers, dairy cows, and the control population (non-animal contact occupational group), and to assess the impact of dairy farming on the gut microbiota of workers. Methods The 16S rRNA full-length amplicon sequencing technology was used to sequence 60 fecal samples from dairy farm workers, 89 from dairy cows, and 50 from the general population. The gut microbiota structure characteristics, including operational taxonomic units (OTUs), alpha diversity, beta diversity, and the composition of species at the phylum, family, and genus levels were analyzed. The differences in gut microbiota among the three groups of samples were compared to explore the impact of occupational exposure on the gut microbiota structure of dairy farm workers. Results A total of 
		                        		
		                        	
2.Effect of galvanic vestibular stimulation on stroke patients with lateropulsion
Xiang GONG ; Menghuan WANG ; Cunshu WU ; Junwen CHEN ; Yue XIAO ; Yun YANG ; Wanting SUN ; Jun LU ; Guangxu XU
Chinese Journal of Rehabilitation Theory and Practice 2024;30(2):210-216
		                        		
		                        			
		                        			ObjectiveTo investigate the effect of galvanic vestibular stimulation on stroke patients with lateropulsion. MethodsFrom February to October, 2023, 30 stroke patients with lateropulsion in the First Affiliated Hospital of Nanjing Medical University were divided into control group (n = 15) and experimental group (n = 15) randomly. The control group received routine rehabilitation and sham galvanic vestibular stimulation, and the experimental group received routine rehabilitation and true galvanic vestibular stimulation, for two weeks. They were assessed with Scale for Contraversive Pushing (SCP), subjective visual vertical (SVV), Line Cancellation Test (LCT), Star Cancellation Test (SCT), Berg Balance Scale (BBS), Holden Functional Ambulation Category (FAC) and Barthel Index (BI) before and after treatment. ResultsAll the indexes improved in both groups after intervention (|t| > 2.461, Z > 3.000, P < 0.05), except the SVV orientation, SVV certainty and SCT in the control group; while the SCP, SVV certainty, LCT and FAC were better in the experimental group than in the control group (|t| > 2.189, Z = -2.862, P < 0.05), and the differences before and after intervention were better in the experimental group than in the control group (|t| > 2.382, P < 0.05), except LCT. SCP was correlated with SVV orientation, SVV certainty, SCT, BBS, BI and FAC (|r| > 0.381, P < 0.05). ConclusionGalvanic vestibular stimulation can improve the lateropulsion, balance, walking function and activities of daily living in stroke patients, which may be related to improvement for spatial cognitive function, especially vertical perception. 
		                        		
		                        		
		                        		
		                        	
3.Study on the application of different-length peripheral intravenous catheters in patients undergoing metabolic and bariatric surgery:a randomized clinical trial
Xiaohui YANG ; Chang LIU ; Weihua YU ; Jionghuang CHEN ; Wanting SHENG ; Xiuzhu CAO ; Xufen ZENG ; Xianghong JIN ; Linfang ZHAO
Chinese Journal of Nursing 2024;59(4):401-407
		                        		
		                        			
		                        			Objective To investigate the appropriate venous access for obese patients undergoing metabolic and bariatric surgery by comparing the clinical outcomes of different lengths of peripheral intravenous catheters.Methods Inpatients who underwent bariatric surgery in a tertiary hospital in Zhejiang from August 2022 to December 2022 were selected as the study population using a fixed-point continuous convenience sampling method.A stratified block randomisation method was used to divide the group into an experimental group 1(mini-midline catheters),an experimental group 2(midline catheters)and a control group(short peripheral intravenous catheters,Short PIVCs).The incidence of catheter-related complications,the rate of extubation due to complications,the duration of catheter retention,the time to first catheter-related complication were compared in the 3 groups.Results A total of 186 patients were included,with 62 patients in each group.The overall incidence of catheter-related complications in experimental group 1,experimental group 2,and control group were 25.81%,8.06%,and 58.06%.The extubation rates due to complications were 19.35%,4.84%,and 41.94%,and the duration of catheter retention was 7.00(6.00,7.00)d,7.00(6.00,7.00)d,6.00(3.00,6.25)d.The differences were statistically different(P<0.05)when comparing the 3 groups.Among them,the differences in the overall incidence of catheter-related complications and the rate of extubation due to complications were statistically significant when comparing experimental group 1 with the control group,experimental group 2 with the control group,and experimental group 1 with experimental group 2(P<0.017);the duration of catheter retention in both experimental group 1 and experimental group 2 were higher than it in the control group,and the differences were statistically different(P<0.017).Conclusion The complication rate of mini-midline catheters and midline catheters is lower than that of short ones,and the indwelling time is consistent with the perioperative period of metabolic and bariatric surgery,which is suitable for use in patients undergoing metabolic and bariatric surgery.
		                        		
		                        		
		                        		
		                        	
4.Group cognitive behavioral therapy for insomnia in the treatment of comorbid insomnia and obstructive sleep apnea: a case report
Min LIU ; Rui ZHAO ; Min CHEN ; Rina SU ; Wanting WEI ; Ping YAO ; Dongsheng LYU
Sichuan Mental Health 2024;37(6):572-575
		                        		
		                        			
		                        			This article reported a patient who initially presented with insomnia complaints and was subsequently diagnosed with severe obstructive sleep apnea (OSA) on polysomnography (PSG). The patient tried continuous positive airway pressure (CPAP)but gave up because wear the ventilator made it more difficult to fall asleep. Then the patient only received group cognitive behavioral therapy for insomnia (CBT-I), which not only alleviated insomnia severity but also promoted severe OSA into mild status. Such case suggested that, firstly, due to the high comorbidity of insomnia and OSA, evaluation of OSA should be considered a part worth enough attention of the clinical diagnosis and treatment of insomnia patients. Secondly, by relieving insomnia, CBT-I can alleviate both nocturnal apnea and daytime somnolence in patients with comorbid insomnia and sleep apnoea (COMISA), so the application of CBT-I should be emphasized in the treatment of such patients. [Funded by the Central Government-guided Local Science and Technology Development Fund Project (number, 2022ZY0028)] 
		                        		
		                        		
		                        		
		                        	
5.Analysis of risk monitoring results for schistosomiasis in Hubei Province from 2015 to 2022
SU Wanting ; CHEN Yanyan ; WANG Hui ; LIU Jianbing ; YANG Junjing
China Tropical Medicine 2024;24(5):526-
		                        		
		                        			
		                        			Abstract: Objective To analyze the epidemic situation and risk factors of schistosomiasis in Hubei Province from 2015 to 2022, and to provide a scientific basis for the goal of all schistosomiasis-endemic counties in the province reaching the elimination standard by 2030. Methods According to the requirements of the National Schistosomiasis Surveillance Plan (2014 edition) and National Schistosomiasis Surveillance Plan (2020 edition), the snail situation and the risk of wild fecal transmission, along with regional distribution in schistosomiasis endemic areas in Hubei Province from 2015 to 2022 were analyzed and the risk was rated. Results From 2015 to 2022, a total of 60 203 risk monitoring environments per time was carried out, with 10 223 460 frames of snails inspected, capturing 2 344 094 snails, among which 1 357 479 live snails, and an average density ranging from 0.07-0.29 snails/0.11 m2. In 2015 and 2017, 11 and 3 schistosomiasis-infected snails were detected respectively, corresponding to 3 and 2 positive snail environments. The proportion of wild feces distribution environment in the total monitoring environment showed a downward trend, with cow dung accounting for the highest proportion (69.27%). A total of 19 549 wild feces were collected, of which 78 were positive for schistosomiasis. Since 2018, only one positive cow dung was found in 2019, and none in other years. From 2015 to 2020, the density of live snails and the proportion of wild feces in the monitoring environment in each risk monitoring county (city, district) had significantly reduced, with areas of higher snail density such as Gongan County, Yangxin County with higher density of live snails decreasing to below 1 per  0.11 m2 from 2017. Among the 60 203 risk monitoring environments, 53 were identified as GradeⅠrisk (not detected since 2020), 1 999 as GradeⅡrisk, and 58 030 as GradeⅢrisk. Conclusions From 2015 to 2022, the overall schistosomiasis epidemic in Hubei Province showed a downward trend. However, the risk of schistosomiasis transmission still exists in some areas. In the future, we should continue to strengthen the epidemic monitoring in key areas, improve the sensitivity and level of monitoring, and prevent the rebound of the epidemic.
		                        		
		                        		
		                        		
		                        	
6.Delay in identification, healthcare-seeking, and definitive diagnosis of tuberculosis among students in Urumqi City from 2010 to 2019
Li MA ; Zhichao LIANG ; Yanggui CHEN ; Weisheng ZHANG ; Hongkai MAO ; Wanting XU ; Mingqin CAO
Journal of Preventive Medicine 2023;35(1):53-56
		                        		
		                        			Objective:
		                        			To investigate the delay in identification, healthcare-seeking, and definitive diagnosis of tuberculosis among students in Urumqi City from 2010 to 2019, and to identify the influencing factors, so as to provide insights into tuberculosis control among students.
		                        		
		                        			Methods:
		                        			The demographic and diagnosis data of tuberculosis patients in Urumqi City from 2010 to 2019 were captured from the Tuberculosis Information Management System of Chinese Disease Control and Prevention Information System. The delay in identification, healthcare-seeking and definitive diagnosis of tuberculosis was analyzed among students, and the factors affecting the delay in identification, healthcare-seeking and definitive diagnosis of tuberculosis were identified using a multivariable logistic regression model. 
		                        		
		                        			Results:
		                        			A total of 996 tuberculosis cases were identified among students in Urumqi City from 2010 to 2019. There were 702 students with delay in identification of tuberculosis (70.48%), 500 students with delay in healthcare-seeking (55.22%) and 534 students with delay in definitive diagnosis (53.61%). Multivariable logistic regression analysis identified active identification (OR=0.116, 95%CI: 0.032-0.420) as a factor affecting delay in identification of tuberculosis, women (OR=1.424, 95%CI: 1.104-1.836), non-local household registration (OR=1.311, 95%CI: 1.016-1.694) and active identification (OR=0.232, 95%CI: 0.064-0.848) as factors affecting delay in healthcare-seeking, and active identification (OR=0.143, 95%CI: 0.032-0.644) as a factor affecting delay in definitive diagnosis of tuberculosis among students.
		                        		
		                        			Conclusions
		                        			There is a high proportion of delay in identification, healthcare-seeking and definitive diagnosis of tuberculosis among students in Urumqi City from 2010 to 2019, and female and non-locally household-registered students were at a high risk of delay in healthcare-seeking for tuberculosis. Active detection and screening of tuberculosis should be reinforced.
		                        		
		                        		
		                        		
		                        	
7.Lipid carriers for mRNA delivery.
Wanting ZHANG ; Yuxin JIANG ; Yonglong HE ; Hamza BOUCETTA ; Jun WU ; Zhongjian CHEN ; Wei HE
Acta Pharmaceutica Sinica B 2023;13(10):4105-4126
		                        		
		                        			
		                        			Messenger RNA (mRNA) is the template for protein biosynthesis and is emerging as an essential active molecule to combat various diseases, including viral infection and cancer. Especially, mRNA-based vaccines, as a new type of vaccine, have played a leading role in fighting against the current global pandemic of COVID-19. However, the inherent drawbacks, including large size, negative charge, and instability, hinder its use as a therapeutic agent. Lipid carriers are distinguishable and promising vehicles for mRNA delivery, owning the capacity to encapsulate and deliver negatively charged drugs to the targeted tissues and release cargoes at the desired time. Here, we first summarized the structure and properties of different lipid carriers, such as liposomes, liposome-like nanoparticles, solid lipid nanoparticles, lipid-polymer hybrid nanoparticles, nanoemulsions, exosomes and lipoprotein particles, and their applications in delivering mRNA. Then, the development of lipid-based formulations as vaccine delivery systems was discussed and highlighted. Recent advancements in the mRNA vaccine of COVID-19 were emphasized. Finally, we described our future vision and perspectives in this field.
		                        		
		                        		
		                        		
		                        	
8.Construction and functional analysis of EGFRvIII CAR-T cells co-expressing IL-15 and CCL19.
Wanqiong CHEN ; Na XIAN ; Shaomei LIN ; Wanting LIAO ; Mingzhu CHEN
Chinese Journal of Biotechnology 2023;39(9):3787-3799
		                        		
		                        			
		                        			The aim of this study was to investigate the functional characteristics and in vitro specific killing effect of EGFRvIII CAR-T cells co-expressing interleukin-15 and chemokine CCL19, in order to optimize the multiple functions of CAR-T cells and improve the therapeutic effect of CAR-T cells targeting EGFRvIII on glioblastoma (GBM). The recombinant lentivirus plasmid was obtained by genetic engineering, transfected into 293T cells to obtain lentivirus and infected T cells to obtain the fourth generation CAR-T cells targeting EGFRvIII (EGFRvIII-IL-15-CCL19 CAR-T). The expression rate of CAR molecules, proliferation, chemotactic ability, in vitro specific killing ability and anti-apoptotic ability of the fourth and second generation CAR-T cells (EGFRvIII CAR-T) were detected by flow cytometry, cell counter, chemotaxis chamber and apoptosis kit. The results showed that compared with EGFRvIII CAR-T cells, EGFRvIII-IL-15-CCL19 CAR-T cells successfully secreted IL-15 and CCL19, and had stronger proliferation, chemotactic ability and anti-apoptosis ability in vitro (all P < 0.05), while there was no significant difference in killing ability in vitro. Therefore, CAR-T cells targeting EGFRvIII and secreting IL-15 and CCL19 are expected to improve the therapeutic effect of glioblastoma and provide an experimental basis for clinical trials.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Receptors, Chimeric Antigen/metabolism*
		                        			;
		                        		
		                        			Glioblastoma/metabolism*
		                        			;
		                        		
		                        			Interleukin-15/metabolism*
		                        			;
		                        		
		                        			Chemokine CCL19/metabolism*
		                        			;
		                        		
		                        			Cell Line, Tumor
		                        			;
		                        		
		                        			T-Lymphocytes/metabolism*
		                        			
		                        		
		                        	
9.Research progress of virtual reality technology in symptom management of palliative care
Wanting XIA ; Yongyi CHEN ; Xiangyu LIU ; Yazhou XIAO ; Xianghua XU
Chinese Journal of Modern Nursing 2023;29(6):717-722
		                        		
		                        			
		                        			With the change of disease spectrum and the acceleration of aging process, the demand for palliative care in China is increasing. Symptom control is the primary task of palliative care, and it is of great significance to improve the quality of life of end-stage patients. This paper summarizes the hardware configuration of virtual reality technology and its scene design, scene implementation and application scope in the symptom management of palliative care, so as to provide reference for the development of virtual reality intervention strategies and methods in the symptom management of palliative care.
		                        		
		                        		
		                        		
		                        	
10.Optimization of conditions for preparation of amidoximated polyacrylonitrile membrane for U (VI) adsorption
Jiaqi CHEN ; Wanting CHENG ; Wenda XU ; Peng LIU ; Fuqiu MA ; Yun XUE
Chinese Journal of Radiological Health 2022;31(2):204-209
		                        		
		                        			
		                        			Objective To optimize conditions for the preparation of amidoximated polyacrylonitrile (PAO) membrane for U (VI) adsorption that can be easily recycled and reused. Methods Using polyacrylonitrile powder as a raw material, the PAO membrane was prepared using the nonsolvent-induced phase separation method under different conditions. The effects of the polyacrylonitrile concentration and temperature and duration of amidoximation in the preparation of casting solution as well as alkali treatment before adsorption on the U (VI) adsorption performance of PAO membrane were investigated. Results Alkali treatment significantly improved the U (VI) adsorption performance of PAO membrane, and the temperature and duration of alkali treatment affected the U (VI) adsorption capacity. The optimal alkali treatment conditions were 0.1 mol/L NaOH, 80 min, and 60℃. The polyacrylonitrile concentration and temperature and duration of amidoximation in the preparation of casting solution influenced the adsorption performance of PAO membrane. The optimal preparation conditions were 10wt% polyacrylonitrile and amidoximation at 65℃ for 18 h. Under the optimal preparation and alkali treatment conditions, the U (VI) adsorption capacity of PAO membrane reached 255 mg/g. Conclusion The PAO membrane has the advantages of simple preparation, high adsorption capacity, and easy recycling and reuse, which can be used as an ideal material for adsorbing U (VI) in wastewater.
		                        		
		                        		
		                        		
		                        	
            

Result Analysis
Print
Save
E-mail